Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Buy
8,076
+1,042
+15% +$144K 0.07% 95
2026
Q2
$904K Buy
7,034
+656
+10% +$76.8K 0.06% 107
2026
Q1
$767K Sell
6,378
-107
-2% -$12.4K 0.06% 108
2025
Q4
$683K Sell
6,485
-22
-0.3% -$2.06K 0.05% 118
2025
Q3
$546K Sell
6,507
-8,831
-58% -$727K 0.04% 133
2025
Q2
$1.21M Sell
15,338
-723
-5% -$57.5K 0.1% 91
2025
Q1
$1.44M Buy
16,061
+9,380
+140% +$876K 0.13% 76
2024
Q4
$665K Sell
6,681
-8,947
-57% -$922K 0.06% 113
2024
Q3
$1.77M Buy
15,628
+345
+2% +$41K 0.16% 61
2024
Q2
$1.89M Buy
+15,283
New +$1.97M 0.19% 55

Other funds holding MRK

Hardy Reed's MRK Position: Q3 2026 in Review

Hardy Reed increased its Merck (MRK) stake by 15% in Q3 2026, buying an estimated $144K and bringing the position to 8,076 shares worth $1.17M. The position accounts for 0.07% of the portfolio, ranked #95.

Hardy Reed first reported a position in MRK in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.89M in Q2 2024. 2,448 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Hardy Reed held 8,076 shares of Merck worth $1.17M as of Q3 2026.
  • Hardy Reed bought 1,042 Merck shares in Q3 2026, an estimated $144K.
  • Merck made up 0.07% of Hardy Reed's portfolio in Q3 2026, its #95 holding.
  • Hardy Reed first reported a position in Merck in Q2 2024 and has held it in 10 quarters since.
  • Hardy Reed's Merck position peaked at $1.89M in Q2 2024.
  • 2,448 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.